An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease
Liquid chromatography coupled with mass spectrometry (LC-MS) metabolomic approaches are widely used to investigate underlying pathogenesis of gastrointestinal disease and mechanism of action of treatments. However, there is an unmet requirement to assess faecal metabolite extraction methods for larg...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/12/11/1110 |
_version_ | 1797464591641346048 |
---|---|
author | Patricia E. Kelly H Jene Ng Gillian Farrell Shona McKirdy Richard K. Russell Richard Hansen Zahra Rattray Konstantinos Gerasimidis Nicholas J. W. Rattray |
author_facet | Patricia E. Kelly H Jene Ng Gillian Farrell Shona McKirdy Richard K. Russell Richard Hansen Zahra Rattray Konstantinos Gerasimidis Nicholas J. W. Rattray |
author_sort | Patricia E. Kelly |
collection | DOAJ |
description | Liquid chromatography coupled with mass spectrometry (LC-MS) metabolomic approaches are widely used to investigate underlying pathogenesis of gastrointestinal disease and mechanism of action of treatments. However, there is an unmet requirement to assess faecal metabolite extraction methods for large-scale metabolomics studies. Current methods often rely on biphasic extractions using harmful halogenated solvents, making automation and large-scale studies challenging. The present study reports an optimised monophasic faecal extraction protocol that is suitable for untargeted and targeted LC-MS analyses. The impact of several experimental parameters, including sample weight, extraction solvent, cellular disruption method, and sample-to-solvent ratio, were investigated. It is suggested that a 50 mg freeze-dried faecal sample should be used in a methanol extraction (1:20) using bead beating as the means of cell disruption. This is revealed by a significant increase in number of metabolites detected, improved signal intensity, and wide metabolic coverage given by each of the above extraction parameters. Finally, we addressed the applicability of the method on faecal samples from patients with Crohn’s disease (CD) and coeliac disease (CoD), two distinct chronic gastrointestinal diseases involving metabolic perturbations. Untargeted and targeted metabolomic analysis demonstrated the ability of the developed method to detect and stratify metabolites extracted from patient groups and healthy controls (HC), highlighting characteristic changes in the faecal metabolome according to disease. The method developed is, therefore, suitable for the analysis of patients with gastrointestinal disease and can be used to detect and distinguish differences in the metabolomes of CD, CoD, and HC. |
first_indexed | 2024-03-09T18:09:22Z |
format | Article |
id | doaj.art-e36cef08965b4864b3597bdf30f5dcc2 |
institution | Directory Open Access Journal |
issn | 2218-1989 |
language | English |
last_indexed | 2024-03-09T18:09:22Z |
publishDate | 2022-11-01 |
publisher | MDPI AG |
record_format | Article |
series | Metabolites |
spelling | doaj.art-e36cef08965b4864b3597bdf30f5dcc22023-11-24T09:13:10ZengMDPI AGMetabolites2218-19892022-11-011211111010.3390/metabo12111110An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal DiseasePatricia E. Kelly0H Jene Ng1Gillian Farrell2Shona McKirdy3Richard K. Russell4Richard Hansen5Zahra Rattray6Konstantinos Gerasimidis7Nicholas J. W. Rattray8Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow G4 0RE, UKSchool of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow Royal Infirmary, Glasgow G12 8QQ, UKStrathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow G4 0RE, UKBacteria, Immunology, Nutrition, Gastroenterology and Omics (BINGO) Group, University of Glasgow, Glasgow G12 8QQ, UKBacteria, Immunology, Nutrition, Gastroenterology and Omics (BINGO) Group, University of Glasgow, Glasgow G12 8QQ, UKBacteria, Immunology, Nutrition, Gastroenterology and Omics (BINGO) Group, University of Glasgow, Glasgow G12 8QQ, UKStrathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow G4 0RE, UKBacteria, Immunology, Nutrition, Gastroenterology and Omics (BINGO) Group, University of Glasgow, Glasgow G12 8QQ, UKStrathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow G4 0RE, UKLiquid chromatography coupled with mass spectrometry (LC-MS) metabolomic approaches are widely used to investigate underlying pathogenesis of gastrointestinal disease and mechanism of action of treatments. However, there is an unmet requirement to assess faecal metabolite extraction methods for large-scale metabolomics studies. Current methods often rely on biphasic extractions using harmful halogenated solvents, making automation and large-scale studies challenging. The present study reports an optimised monophasic faecal extraction protocol that is suitable for untargeted and targeted LC-MS analyses. The impact of several experimental parameters, including sample weight, extraction solvent, cellular disruption method, and sample-to-solvent ratio, were investigated. It is suggested that a 50 mg freeze-dried faecal sample should be used in a methanol extraction (1:20) using bead beating as the means of cell disruption. This is revealed by a significant increase in number of metabolites detected, improved signal intensity, and wide metabolic coverage given by each of the above extraction parameters. Finally, we addressed the applicability of the method on faecal samples from patients with Crohn’s disease (CD) and coeliac disease (CoD), two distinct chronic gastrointestinal diseases involving metabolic perturbations. Untargeted and targeted metabolomic analysis demonstrated the ability of the developed method to detect and stratify metabolites extracted from patient groups and healthy controls (HC), highlighting characteristic changes in the faecal metabolome according to disease. The method developed is, therefore, suitable for the analysis of patients with gastrointestinal disease and can be used to detect and distinguish differences in the metabolomes of CD, CoD, and HC.https://www.mdpi.com/2218-1989/12/11/1110mass spectrometrymetabolite extractioninflammatory bowel diseaseCrohn’s diseasecoeliac disease |
spellingShingle | Patricia E. Kelly H Jene Ng Gillian Farrell Shona McKirdy Richard K. Russell Richard Hansen Zahra Rattray Konstantinos Gerasimidis Nicholas J. W. Rattray An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease Metabolites mass spectrometry metabolite extraction inflammatory bowel disease Crohn’s disease coeliac disease |
title | An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease |
title_full | An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease |
title_fullStr | An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease |
title_full_unstemmed | An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease |
title_short | An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease |
title_sort | optimised monophasic faecal extraction method for lc ms analysis and its application in gastrointestinal disease |
topic | mass spectrometry metabolite extraction inflammatory bowel disease Crohn’s disease coeliac disease |
url | https://www.mdpi.com/2218-1989/12/11/1110 |
work_keys_str_mv | AT patriciaekelly anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT hjeneng anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT gillianfarrell anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT shonamckirdy anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT richardkrussell anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT richardhansen anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT zahrarattray anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT konstantinosgerasimidis anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT nicholasjwrattray anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT patriciaekelly optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT hjeneng optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT gillianfarrell optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT shonamckirdy optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT richardkrussell optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT richardhansen optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT zahrarattray optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT konstantinosgerasimidis optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease AT nicholasjwrattray optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease |